Cargando…

Pimecrolimus Cream 1% in the Management of Atopic Dermatitis in Pediatric Patients: A Meta-Analysis

OBJECTIVE: To evaluate the efficacy and safety of pimecrolimus cream 1% in the treatment of AD in the pediatric population. METHODS: PubMed, EMBASE, Web of Science and Cochrane library databases were searched till July 2013. The randomized and nonrandomized blinded studies of pimecrolimus cream 1% a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chunyun, Sheng, Youyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972203/ https://www.ncbi.nlm.nih.gov/pubmed/24691404 http://dx.doi.org/10.1371/journal.pone.0093095

Ejemplares similares

Retraction: Pimecrolimus Cream 1% in the Management of Atopic Dermatitis in Pediatric Patients: A Meta-Analysis
Publicado: (2014)

Pimecrolimus cream in the management of patients with atopic eczema
por: Spergel, Jonathan M
Publicado: (2009)

Is pimecrolimus cream (1%) an appropriate therapeutic agent for the treatment of external ear atopic dermatitis?
por: Beriat, Güçlü Kaan, et al.
Publicado: (2012)

Efficacy and tolerance of tacrolimus and pimecrolimus for atopic dermatitis: a meta-analysis
por: Yin, Zhiqiang, et al.
Publicado: (2011)

Observational study of pimecrolimus 1% cream for prevention of transcutaneous sensitization in children with atopic dermatitis during their first year of life
por: Murashkin, Nikolay N., et al.
Publicado: (2023)

Treatment of atopic dermatitis with pimecrolimus – impact on quality of life
por: Lee, Hae-Hyuk, et al.
Publicado: (2007)

Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective
por: Chu, Chia-Yu, et al.
Publicado: (2023)

Formulary Review of Therapeutic Alternatives for Atopic Dermatitis: Focus on Pimecrolimus
por: Weinberg, Jeffery M.
Publicado: (2005)

Treatment of Facial Seborrheic Dermatitis with Pimecrolimus Cream 1%: An Open-Label Clinical Study in Korean Patients
por: Kim, Byung-Soo, et al.
Publicado: (2007)

Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood
por: Boms, Stefanie, et al.
Publicado: (2004)

Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
por: Luger, Thomas, et al.
Publicado: (2015)

Experts’ Consensus on the Use of Pimecrolimus in Atopic Dermatitis in China: A TCS-Sparing Practical Approach
por: Zhao, Zuotao, et al.
Publicado: (2022)

A Pilot Study of 1% Pimecrolimus Cream for the Treatment of Childhood Segmental Vitiligo
por: Shim, Woo-Haing, et al.
Publicado: (2013)

Safety and efficacy of pimecrolimus versus vehicle for the treatment of atopic dermatitis in adults and paediatric population: a systematic review and meta-analysis
por: Akhtar, Sareema E., et al.
Publicado: (2023)

Reiter's disease: Circinate balanitis as alone preceding presentation - Successfully treated with pimecrolimus 1% cream
por: Kumar, Sumir, et al.
Publicado: (2015)

Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling
por: Shin, Nari, et al.
Publicado: (2021)

Relative efficacy of pimecrolimus cream and triamcinolone acetonide paste in the treatment of symptomatic oral lichen planus
por: Arunkumar, Shantala, et al.
Publicado: (2015)

Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis
por: Blauvelt, Andrew, et al.
Publicado: (2022)

The Effect of Pimecrolimus Cream 1% Compared with Triamcinolone Acetonide Paste in Treatment of Atrophic-Erosive Oral Lichen Planus
por: Pakfetrat, Atessa, et al.
Publicado: (2015)

Comparative Evaluation of Pimecrolimus Cream 1% and Triamcinolone Aceonide Paste in Treatment of Atrophic–Erosive Oral Lichen Planus
por: Bajoria, Atul Anand, et al.
Publicado: (2023)

Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis
por: Hoy, Sheridan M.
Publicado: (2022)

Efficacy of Heparinoid Cream Containing Pseudo-Ceramide for Remission of Atopic Dermatitis
por: Matsuoka, Megumi, et al.
Publicado: (2021)

Correction to: Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis
por: Hoy, Sheridan M.
Publicado: (2023)

The Suppressive Effect of Mamiran Cream on Atopic Dermatitis-Like Skin Lesions In Vivo
por: Aierken, Kailibinuer, et al.
Publicado: (2021)

A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis
por: Bissonnette, Robert, et al.
Publicado: (2022)

Pimecrolimus increases the melanogenesis and migration of melanocytes in vitro
por: Xu, Ping, et al.
Publicado: (2017)

The Efficacy and Safety of Pimecrolimus in Patients With Facial Seborrheic Dermatitis: A Systematic Review of Randomized Controlled Trials
por: Alsmeirat, Odeh, et al.
Publicado: (2022)

Health Plan Budget Impact Analysis for Pimecrolimus
por: Chang, Jane, et al.
Publicado: (2005)

Consensus Conference on Clinical Management of pediatric Atopic Dermatitis
por: Galli, Elena, et al.
Publicado: (2016)

Administrative Claims Analysis of Utilization and Costs of Care in Health Plan Members With Atopic Dermatitis Who Had Prior Use of a Topical Corticosteroid and Who Initiate Therapy With Pimecrolimus or Tacrolimus
por: Delea, Thomas E., et al.
Publicado: (2007)

Microneedling in Combination with Topical Pimecrolimus 1% versus Topical Pimecrolimus 1% for the Treatment of Refractory Stable Vitiligo: A Randomized Clinical Trial
por: Iraji, Fariba, et al.
Publicado: (2021)

Successful management of Zoons balanitis with the combination of pimecrolimus and excimer laser
por: Udare, Satish, et al.
Publicado: (2022)

A New Approach to Atopic Dermatitis Control with Low-Concentration Propolis-Loaded Cold Cream
por: Martin, Bianca Aparecida, et al.
Publicado: (2021)

The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2021)

Efficacy of probiotics in pediatric atopic dermatitis: A systematic review and meta‐analysis
por: Xue, Xiali, et al.
Publicado: (2023)

Recent insights into the management of treatment-resistant pediatric atopic dermatitis
por: Naik, Piyu Parth
Publicado: (2022)

Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies
por: Gong, Xiaohua, et al.
Publicado: (2021)

Allergic Contact Dermatitis and Autoeczematization to Proctosedyl® Cream and Proctomyxin® Cream
por: Hughes, J.D. Matthew, et al.
Publicado: (2018)

Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis
por: Danby, Simon G., et al.
Publicado: (2022)

Potential application of PS-OCT in the safety assessment of non-steroidal topical creams for atopic dermatitis treatment
por: Duan, M. Q., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e2bs8v5nupf17v9qnbei8s3j7q